Business · Companies · 3 hrs ago
Teva to hold R&D event in New York on November 11
Teva Pharmaceutical Industries says it will hold an R&D Day in New York City on Wednesday, November 11, 2026.
The event is scheduled to run from 8:30 a.m.
to 12:30 p.m.
Eastern Time.
Teva’s leaders plan to discuss the company’s research and development pipeline, meaning the treatments it is working on.
They will also discuss the pipeline’s potential to create value over the next five years.
The event will cover Teva’s effort to become an innovative biopharma company through its Pivot to Growth strategy.
In-person attendance is limited to invited analysts and institutional investors.
Teva has not provided further details about the event in the announcement.
Teva Pharmaceutical Industries will hold an R&D Day in New York on November 11, 2026.
Presentations are scheduled to begin at 8:30 a.m. Eastern Time and end at 12:30 p.m.
Teva’s leadership will discuss the company’s research and development pipeline and its potential to create value over the next five years.
The event will also cover Teva’s transformation into an innovative biopharma company through its Pivot to Growth strategy.
In-person attendance is by invitation only because capacity is limited.
- Who
- Teva Pharmaceutical Industries Ltd. will host the event, with company leadership presenting.
- What
- An R&D Day covering Teva’s pipeline, value-creation potential and transformation strategy.
- When
- Wednesday, November 11, 2026; presentations are scheduled from 8:30 a.m. to 12:30 p.m. Eastern Time.
- Where
- New York City.
- Why
- To discuss Teva’s R&D pipeline, its near-term value-creation potential over the next five years, and its transformation through the Pivot to Growth strategy.
This story does not have two clearly opposing sides.
Teva announced it would hold an R&D Day on November 11.
The event is scheduled to take place in New York, with presentations from 8:30 a.m. to 12:30 p.m. Eastern Time.
- Company
- Teva Pharmaceutical Industries Ltd.
- Event
- R&D Day
- Date
- November 11, 2026
- Location
- New York City
- Presentations
- 8:30 a.m.–12:30 p.m. Eastern Time
- In-person attendance
- By invitation only






